Replies to post #237204 on Biotech Values

[DewDiligence]

Re: RVNC /upper-limb spasticity

It took the highest (500mg) dose to come in with a .048 statsig number. Don't know how this will fare in a [phase-3 trial].

The effect size (and duration of effect) seems to be consistent with what RVNC was expecting, although the actual numeric value hasn’t yet been disclosed (pending presentation at a medical conference). The p-value in the 500mg cohort would presumably have looked better if the trial had enrolled 128 patients, as planned, instead of the actual 83 patients due to COVID.